Which all are the conditions in which vasodilation occur and vasoconstric tion occurs
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive information from the textbooks. Let me compile this into a thorough, well-organized answer.
Here is a complete, textbook-based overview of all the major conditions and mediators that cause vasodilation and vasoconstriction, organized by mechanism.
Vasodilation vs Vasoconstriction: Conditions and Causes
VASODILATION
1. Metabolic / Local Tissue Conditions
These are the most physiologically important causes. When tissues have increased metabolic demand or reduced nutrient supply, local vasodilator mechanisms kick in:
| Condition | Mechanism |
|---|---|
| Increased tissue metabolism (e.g., exercise) | Build-up of vasodilator metabolites |
| Hypoxia (low O2) | Direct relaxation of vascular smooth muscle; adenosine release |
| High altitude | Reduced O2 availability -> compensatory vasodilation |
| Pneumonia | Hypoxia-driven local vasodilation |
| Carbon monoxide poisoning | Blocks O2 transport -> tissue hypoxia -> vasodilation |
| Cyanide poisoning | Blocks cellular O2 use -> vasodilation |
| Raised CO2 / acidosis (low pH / raised H+) | Especially potent in cerebral circulation; CO2 is the dominant cerebral vasodilator |
| Raised K+ (potassium) | Released during muscle contraction; causes arteriolar dilation |
| Raised lactate / adenosine | Byproducts of increased metabolism |
| Vitamin B deficiency (beriberi - thiamine, niacin, riboflavin deficiency) | Impairs ATP production -> smooth muscle relaxes -> widespread vasodilation (can double or triple peripheral blood flow) |
| Glucose deficiency | Local arteriolar dilation |
| Reactive hyperemia | After a period of arterial occlusion, repayment of O2 debt causes marked vasodilation |
| Active hyperemia | Exercise or increased organ activity causes proportional increase in blood flow |
- Guyton and Hall Textbook of Medical Physiology, Chapters 17-18
2. Neural Conditions
| Condition | Mechanism |
|---|---|
| Sympathetic stimulation of skeletal muscle vessels | Epinephrine from adrenal medulla acts on beta-2 adrenergic receptors -> vasodilation |
| Parasympathetic stimulation (certain vessels) | Acetylcholine -> NO release -> vasodilation |
| Vasovagal (reflex/emotional) syncope | Anterior hypothalamus activates sympathetic vasodilator system in muscles + vagal bradycardia -> BP drops -> fainting |
| Spinal cord injury (autonomic dysreflexia) | Disruption of descending sympathetic control |
- Guyton and Hall, p.225; Costanzo Physiology 7e
3. Humoral / Hormonal Mediators Causing Vasodilation
| Mediator | Source / Situation |
|---|---|
| Nitric Oxide (NO) - "EDRF" | Released by endothelium in response to shear stress, ACh, bradykinin |
| Bradykinin | Dilates arterioles; increases capillary filtration |
| Histamine | Released during trauma/allergy; dilates arterioles (while constricting venules) -> local edema |
| Prostacyclin (PGI2) | Endothelial arachidonic acid metabolite; opens KATP channels |
| Prostaglandin E2 (PGE2) | Vasodilator in most vascular beds |
| ANP (Atrial Natriuretic Peptide) | Released by atria in response to raised atrial pressure; causes vasodilation |
| Epinephrine (via beta-2) | Low doses; beta-2 receptor-mediated vasodilation in skeletal muscle, liver |
| Dopamine | Low dose dopamine -> DA1 receptors in renal/mesenteric beds -> vasodilation |
| Adrenomedullin, Apelin | Peptide vasodilators |
| Endothelin via ETB receptor | ETB receptor on endothelium triggers NO release -> vasodilation |
| CO2 | Direct smooth muscle relaxant; activates sympathetic system (indirect), but local effect is vasodilation |
| Acetylcholine | Endothelium-dependent (NO mediated) vasodilation in coronary arteries (if endothelium is intact) |
- Braunwald's Heart Disease (ETABLE 47.1); Costanzo Physiology 7e, p.181; Barash Clinical Anesthesia
4. Autoregulation - Special Cases
- Autoregulation: When arterial pressure falls, arterioles automatically dilate to maintain constant blood flow (myogenic hypothesis - reduced stretch -> smooth muscle relaxes).
- Coronary circulation: Vasodilates in response to hypoxia and adenosine.
- Cerebral circulation: Vasodilates in response to raised CO2/H+.
- Pulmonary circulation: Opposite to systemic - hypoxia causes vasoconstriction (HPV - see below).
VASOCONSTRICTION
1. Neural Causes
| Condition | Mechanism |
|---|---|
| Sympathetic nervous system activation (fight or flight) | Norepinephrine -> alpha-1 adrenergic receptors -> vasoconstriction in skin, viscera, most organs |
| Cold exposure | Sympathetic cutaneous vasoconstriction to conserve heat |
| Hypothermia | Sympathetic-mediated vasoconstriction |
| Emotional stress/pain | Sympathetic activation |
| Hemorrhage / hypovolemia | Baroreceptor reflex -> sympathetic vasoconstriction to maintain BP |
| Alpha-2 receptor stimulation (peripheral) | E.g., peripheral alpha-2 agonists -> vasoconstriction |
2. Humoral / Hormonal Mediators Causing Vasoconstriction
| Mediator | Source / Situation |
|---|---|
| Norepinephrine | Sympathetic nerve endings -> alpha-1 receptor |
| Angiotensin II | RAAS activation (heart failure, hemorrhage, renal artery stenosis, dehydration) |
| Vasopressin (ADH/AVP) | Released in response to hyperosmolality, hypovolemia |
| Endothelin-1 (ET-1) | Released from endothelium in response to hypoxia, shear stress, thrombin, cytokines; acts via ETA receptor -> potent vasoconstriction |
| Thromboxane A2 (TXA2) | Released by platelets on vessel injury; causes local vasoconstriction + platelet aggregation |
| Serotonin (5-HT) | Released from damaged vessel walls; causes local vasoconstriction (also implicated in migraine vasospasm) |
| Prostaglandin F2 (PGF2) | Vasoconstrictor prostaglandin |
| Neuropeptide Y | Co-released with norepinephrine; powerful vasoconstrictor |
| Urotensin II | Potent vasoconstrictor peptide |
| Epinephrine (high dose, via alpha-1) | Overrides beta-2 effects at high concentrations |
- Costanzo Physiology 7e, p.181; Braunwald's Heart Disease ETABLE 47.1
3. Hypoxia in the Pulmonary Circulation (Unique!)
- Hypoxic Pulmonary Vasoconstriction (HPV): Unlike systemic vessels (where hypoxia causes vasodilation), pulmonary vessels constrict in response to alveolar hypoxia. This redirects blood away from poorly ventilated lung segments - a critical mechanism for matching ventilation and perfusion (V/Q matching).
4. Disease States Associated with Vasoconstriction
| Disease/Condition | Mechanism |
|---|---|
| Heart failure | RAAS, sympathetic activation -> angiotensin II, norepinephrine, vasopressin -> peripheral vasoconstriction (increases afterload) |
| Septic shock (later phase) | Vasopressors needed due to pathological vasodilation, but endothelin and RAAS also activated |
| Hypertension | Sustained sympathetic overactivity + RAAS |
| Raynaud's phenomenon | Exaggerated sympathetic/vascular response to cold -> digital vasoconstriction |
| Sickle cell disease | Hypothermia-associated vasoconstriction precipitates sickling |
| Autonomic dysreflexia | Spinal injury -> unopposed sympathetic below injury level -> severe vasoconstriction |
| Renal vasoconstriction in liver cirrhosis | Splanchnic vasodilation activates compensatory RAAS + sympathetic -> renal vasoconstriction, ascites, hepatorenal syndrome |
Summary Table
| Category | Vasodilation | Vasoconstriction |
|---|---|---|
| Metabolic | Hypoxia (systemic), CO2/H+, K+, adenosine, lactate, heat | Cold temperature |
| Neural | Beta-2 adrenergic (Epi), ACh (parasympathetic), vasovagal | Alpha-1 adrenergic (NE), sympathetic activation |
| Hormonal | NO, Bradykinin, Histamine (arterioles), PGI2, PGE2, ANP, Dopamine | Angiotensin II, AVP, Endothelin-1, Thromboxane A2, Serotonin, Neuropeptide Y |
| Pulmonary | Hyperoxia, alkalosis, NO | Hypoxia (HPV), acidosis, ET-1 |
| Autoregulation | Fall in BP (arteriolar relaxation) | Rise in BP (myogenic contraction) |
| Disease states | Sepsis (early), beriberi, anemia, cirrhosis (splanchnic), AV fistula | Heart failure (RAAS), hemorrhage, hypertension, Raynaud's, autonomic dysreflexia |
Sources: Guyton & Hall Medical Physiology; Costanzo Physiology 7e; Braunwald's Heart Disease; Barash Clinical Anesthesia; Katzung Pharmacology 16e
This is a shared conversation. Sign in to Orris to start your own chat.